Printed from https://fiscalreceipts.com/program/0604386A/ — data as of August 12, 2026. Every figure is citation-backed; see the page online for per-number provenance.
Biotechnology for Materials - Dem/Val
Budget Figures
FY2026 award data is a partial year — USASpending awards are reported on a rolling basis and the fiscal year does not close until September 30. why partial FY2026 data? →
| Fiscal year | Amount |
|---|---|
| FY25 | $10.7MR-1 TOA · PB2026 |
| FY26 | $0P-40 detail · PB2026 |
The vertical scale does not start at zero: the baseline sits just below this program’s smallest year, so a low point on this line is not a small amount. Read the shape for direction and the grid below for the figures.
● actuals (line) · ○ enacted · ◇ request — gaps are editions the program is absent from, never interpolated.
| Series | FY25 |
|---|---|
| Enacted | $10.7M |
| Request | $20.9M |
blank = series not published for this year; – = absent from that edition.
Program Lineage
No predecessor/successor lineage was recorded for this program element — no FY-to-FY transfer into or out of this line was stated in the ingested J-books, and none was inferred from the program structure.
Description
Mission — Biotechnology for Materials - Dem/Val
This Project will create a pipeline to down-select promising biotechnology capabilities towards fielded novel solutions for warfighter needs by enabling prototyping at an efficiency and speed greater than is currently possible, through integration of "cutting-edge" instrumentation and robotics in laboratory and armament/warfare centers/depots testing & evaluation systems. T-BRSC will deliver biotechnology advanced evaluations that exhibit Defense supply chain resiliency by providing alternative means of sourcing critical materials (e.g. jet fuel precursors, energetic precursors, lubricants, epoxies, anti-fouling compounds, recovery of rare earth elements) for transition into service acquisition programs. T-BRSC's comprehensive DoD investment strategy will develop the necessary biotechnology pipeline from demonstration and prototyping to manufacture and fielding, to reduce the risk of technological overmatch by adversaries and enable U.S. military and national security objectives for the future. This will provide Supply Chain Resiliency to the U.S. military, while enabling U.S. industry to support military and national security objectives, as well as de-risking cross-cutting and dual-use technologies necessary to drive commercialization and promote the U.S. Bioeconomy to compete with adversaries. Work in this Project complements PE 0603386A (Biotechnology for Materials - Advanced Research) / CP7 (Biotechnology Demonstration and Evaluation). The cited work is consistent with the Under Secretary of Defense for Research and Engineering priority focus areas and the Army Modernization Strategy. Work in this Project is performed by Assistant Secretary of the Army for Acquisition, Logistics and Technology and the Army Research, Development, Test and Evaluation (RDT&E) Enterprise.
Mission — Biotechnology for Materials - Dem/Val
This Project will create a pipeline to down-select promising biotechnology capabilities towards fielded novel solutions for warfighter needs by enabling prototyping at an efficiency and speed greater than is currently possible, through integration of "cutting-edge" instrumentation and robotics in laboratory and armament/warfare centers/depots testing & evaluation systems. T-BRSC will deliver biotechnology advanced evaluations that exhibit Defense supply chain resiliency by providing alternative means of sourcing critical materials (e.g. jet fuel precursors, energetic precursors, lubricants, epoxies, anti-fouling compounds, recovery of rare earth elements) for transition into service acquisition programs. T-BRSC's comprehensive DoD investment strategy will develop the necessary biotechnology pipeline from demonstration and prototyping to manufacture and fielding, to reduce the risk of technological overmatch by adversaries and enable U.S. military and national security objectives for the future. This will provide Supply Chain Resiliency to the U.S. military, while enabling U.S. industry to support military and national security objectives, as well as de-risking cross-cutting and dual-use technologies necessary to drive commercialization and promote the U.S. Bioeconomy to compete with adversaries. Work in this Project complements PE 0603386A (Biotechnology for Materials - Advanced Research) / CP7 (Biotechnology Demonstration and Evaluation). The cited work is consistent with the Under Secretary of Defense for Research and Engineering priority focus areas and the Army Modernization Strategy. Work in this Project is performed by Army Research, Development, Test and Evaluation (RDT&E) Enterprise.
Justification
Accomplishments & Planned Programs (1)
Title: Biotechnology for Materials - Dem/Val
Description: This task evaluates the application of emerging biotechnologies and bio-manufactured materials for acquisition programs to address resilient military supply chain for needs.
Budget Line Items(workbook-cited)
P-1/R-1 workbook Total Obligation Authority basis (USD thousands) · PB2026.
Exhibit R-1
| Account | Org | Type | Amount |
|---|---|---|---|
| Research, Development, Test and Evaluation, Army | A | FY25 Enacted | $10.7M |
| Research, Development, Test and Evaluation, Army | A | FY25 Total | $10.7M |
Budget Details(R-2/P-40 facts)
J-book detail basis (R-2/P-40, USD millions) · PB2026 — a different accounting basis from the P-1/R-1 workbook TOA above; where the two disagree, the reconciliation strip under Budget Figures shows both.
Wider than this screen — swipe the table sideways for the remaining fiscal-year columns.
| Project | FY25 Total | FY26 Request |
|---|---|---|
| Program Element | $10.7M | $0 |
| CQ9: Biotechnology for Materials - Dem/Val | $10.7M | — |
No follow-the-dollar view — this program's awards haven't been crosswalked at high confidence (flows cover 17 of 1,741 programs). why coverage is partial? →
Awards
No awards are linked to this program element at high confidence — the budget→award crosswalk only asserts links it can defend, and this line has none yet.
Lobbying Mentions
No Senate LDA lobbying filing in the tracked data mentions this program element by code or alias.
Oversight
Department-level designation (not specific to this program)
GAO lists 5 high-risk areas for DOD as a whole. That designation covers the department, not Biotechnology for Materials - Dem/Val — no program-specific GAO finding for this line is in the ingested data. See the DOD oversight record.
No research dossier for this program — dossiers cover 50 of 1,741 programs, the largest fully J-book-detailed lines by FY2026 requested dollars. why no dossier here? →